Advertising

Five things for pharma marketers to know: Thursday, April 20, 2017

Five things for pharma marketers to know: Thursday, April 20, 2017

By

Tesaro discloses price for new drug that differs from FDA-approved dosage; uniQure discontinues Glybera; O'Reilly leaves Fox

PhRMA debuts new ads in Go Boldly campaign

PhRMA debuts new ads in Go Boldly campaign

By

PhRMA worked with WPP Health & Wellness and Young & Rubicam on creative for the ads.

Some brands thought to shift online ad dollars, creating uncertainty for WebMD

Some brands thought to shift online ad dollars, creating uncertainty for WebMD

By

This and other changes in the market have created demand for new offerings, like mobile-friendly sites, video, and patient communities.

Gilead, Astellas also suspend ads on 'The O'Reilly Factor'

Gilead, Astellas also suspend ads on 'The O'Reilly Factor'

By

Bayer, Eli Lilly, GlaxoSmithKline, and Sanofi have suspended advertising on the show, according to news reports.

Five things for pharma marketers to know: Wednesday, April 5, 2017

Five things for pharma marketers to know: Wednesday, April 5, 2017

By

GSK pulls ads from "The O'Reilly Factor"; the FDA approves drug for Huntington's disease patients; lawmakers may remove pre-existing conditions requirement

McCann Health's June Laffey on why change is good in health

McCann Health's June Laffey on why change is good in health

The president of the 2017 Lions Health pharma jury shares campaigns that incorporate technology, innovation, and creative thinking to impact behaviors and change lives.

Drummy passes the torch at Heartbeat, moves to chairman role

Drummy passes the torch at Heartbeat, moves to chairman role

By

Agency vets Nadine Leonard and James Talerico to co-lead Publicis-owned shop.

The DTC Ads of 2016 That Shouldn't Have Happened

The DTC Ads of 2016 That Shouldn't Have Happened

By

Pharma marketers are producing plenty of exceptional creative work in the DTC realm. There are also plenty that prompt quick checks to make sure that one hasn't inadvertently clicked over to The Onion.

The Top 10 DTC Ads of 2016

The Top 10 DTC Ads of 2016

Mary Skoyles finds that DTC ads are getting better. "There's a lot of interesting work being done," she says. "There are more chances being taken."

The 2017 DTC Report: All the data in one place

The 2017 DTC Report: All the data in one place

Drugmakers again spent more on DTC advertising in 2016 than the year before.

Five things for pharma marketers to know: Friday, March 17, 2017

Five things for pharma marketers to know: Friday, March 17, 2017

By

The FDA delays final rule related to off-label use; Amgen's Repatha reduces risk of death by 20%, study finds; FDA rejects AstraZeneca's hyperkalaemia drug

MSCG's Mark Friedman on Ads with Animals

MSCG's Mark Friedman on Ads with Animals

The chief creative officer takes a look at campaigns in and outside the U.S.

Doctors seek more transparency from drugmakers: ePharma panel

Doctors seek more transparency from drugmakers: ePharma panel

By

Pharmaceutical companies often blur the lines between a drug's risks and benefits in ads, and that frustrates physicians.

Another Pharmageddon? The Looming Threat to 2017 Ad Budgets

Another Pharmageddon? The Looming Threat to 2017 Ad Budgets

By

Despite budgets bouncing back from a decrease in 2015, big threats have appeared that may temper future plans, Iskowitz writes.

MAHF honors Abbate and Lazur, Future Famers

MAHF honors Abbate and Lazur, Future Famers

By

The Medical Advertising Hall of Fame recognized dozens of industry leaders and rising agency executives.

Almost one-third of programmatic ads violate IAB guidelines, study finds

Almost one-third of programmatic ads violate IAB guidelines, study finds

By

The report identifies four major issues of the 28% that were found to abuse IAB's standards.

How To Make A Doctor Happy: Take Away the Brand Message in a Drug Ad

How To Make A Doctor Happy: Take Away the Brand Message in a Drug Ad

The presumption is Dr. A saw ad B, clicked on it, went to the site and within C time, prescribed product D.

Five things for pharma marketers to know: Monday, February 6, 2017

Five things for pharma marketers to know: Monday, February 6, 2017

By

Novo Nordisk CEO describes 'volatile' pricing environment; Lilly to cut 200 research and development jobs; pharma opts out of Super Bowl this year

Merck campaign shows impact of shingles

Merck campaign shows impact of shingles

By

To drive the point home, the ads even feature an image of an actual case of shingles. The blistering red rash appears on-screen for several seconds.

Mike Lazur, 2017 MAHF inductee, on his medical advertising destiny

Mike Lazur, 2017 MAHF inductee, on his medical advertising destiny

By

He played a leading role during Torre Lazur's glory era as "the launch agency." Now he is being inducted into the Medical Advertising Hall of Fame.

It's Time for the Healthcare Industry to Take Advantage of Programmatic

It's Time for the Healthcare Industry to Take Advantage of Programmatic

Still, pharmaceutical marketers must remember that maintaining regulatory compliance is all-important.

Klick Health's Elliot Langerman on the Power of Persuasion

Klick Health's Elliot Langerman on the Power of Persuasion

Here are six global campaigns that make the case for persuasion.

Day 1 at JP Morgan: Pricing is top of mind for pharma CEOs

Day 1 at JP Morgan: Pricing is top of mind for pharma CEOs

By

The questions being asked about how drugs are priced are weighing heavily on pharma leaders, and they know the issue is not going away.

GSW's Erik Slangerup on Ads with Heart

GSW's Erik Slangerup on Ads with Heart

The heart is a tireless worker, beating day and night. When we're telling stories for healthcare brands, we should remember what it takes to infuse real feeling, to get people to care.

How pharma can stay compliant when using programmatic

How pharma can stay compliant when using programmatic

By

The risk of fraud is also very real, especially in an industry that already faces privacy and compliance challenges, one expert says.

Mylan CEO defends EpiPen strategy, questions pricing model in the U.S.

Mylan CEO defends EpiPen strategy, questions pricing model in the U.S.

By

Heather Bresch's appearance at industry summit came after she declined to attend a congressional hearing scheduled for the same day.

Five things for pharma marketers to know: Monday, November 28, 2016

Five things for pharma marketers to know: Monday, November 28, 2016

By

J&J in talks to buy Actelion; Novo Nordisk pulls ads on Breitbart News; Takeda to market Ninlaro in Europe

Pharma Marketers Using Programmatic, Consider Privacy and Measurement

Pharma Marketers Using Programmatic, Consider Privacy and Measurement

There's a reason pharma lags on the programmatic adoption curve: It's a heavily regulated industry, and there are concerns around privacy.

PulsePoint launches health vertical for programmatic advertising

PulsePoint launches health vertical for programmatic advertising

By

The programmatic advertising technology company also hired Chris Neuner as SVP and GM of digital health.

Centron's Letty Albarran Talks Ads That Get Personal

Centron's Letty Albarran Talks Ads That Get Personal

Here are six campaigns that connect with the patient on a personal level.

Opinion

Newsletters

MM&M's T40

Top 40 Healthcare Transformers

MM&M honors 40 upstarts and veteran innovation gurus.

Top 10 Innovation Catalysts

For the first time MM&M honors a group of 10 agency execs.